Public health challenges around anaphylaxis to be discussed in Brussels
A breakfast briefing on the public health challenges of anaphylaxis takes place at the European Parliament on 22 November.
Anaphylaxis (an-a-fi-LAK-sis) is a serious, life-threatening allergic reaction. If you are allergic to a substance, your immune system overreacts to this allergen by releasing chemicals that cause allergy symptoms.
The event is hosted by Mairead McGuinness MEP, Vice President of the European Parliament and member of the Committee on the Environment, Public Health and Food Safety, on behalf of Medicines for Ireland, the representative body for the Irish generic and biosimilar medicines industry.
The briefing will discuss the public health challenges around anaphylaxis and access to Adrenaline Auto-Injectors (AAIs) in Europe, with a particular focus on good policy practice as demonstrated by Member States, such as Ireland.
AAI can save lives when anaphylactic shock occur and Ireland has recently eased access to AAIs in public and workplaces. The aim of this stakeholder event is to debate and examine how to increase awareness of and access to AAIs in practice, and the roles of all relevant stakeholders – legislators, policymakers, healthcare professionals and others – in achieving this objective.